Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cigna Corp (CI) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance

Cigna CorpTrade
KraneShares Electric Vehicles and Future MobilityTrade

Price performance (Past 24H)

Key statistics

Cigna Corp vs KraneShares Electric Vehicles and Future Mobility — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while KraneShares Electric Vehicles and Future Mobility trades at $30.84. The key difference: Cigna Corp pays a 2.24% dividend while KraneShares Electric Vehicles and Future Mobility pays none. Which is the better fit depends on your goals.

CIKARS
Market Cap
$73.56B
Sector
HealthSector/Thematic
52-Week High
$311.00$38.01
52-Week Low
$244.41$25.59
Enterprise Value
$98.27B
Dividend Yield
2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cigna Corp

Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.

The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.

KraneShares Electric Vehicles and Future Mobility

KARS trades at $30.86, up 2.51% today, with a bullish technical signal but bearish moving averages. Recent news highlights global EV sales growth, particularly in Europe and China, though U.S. adoption lags. The stock shows strong momentum with RSI_6 at 80.23 indicating overbought conditions, while support and resistance cluster around $30-$31.

The outlook for KARS is mixed; positive EV industry trends support growth, but high RSI suggests near-term pullback risk. Investment opportunity lies in global EV expansion, while risks include U.S. market hesitation and competitive pressures from Chinese automakers.

Returns comparison

Trailing returns across standard periods

About Cigna Corp

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.

Read more on CI

About KraneShares Electric Vehicles and Future Mobility

KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.

Read more on KARS